Related Experiment Video

Updated: Jul 20, 2026

Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy
04:41

Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy

Published on: October 13, 2023

The Ca(v)2.3 voltage-gated calcium channel in epileptogenesis--shedding new light on an enigmatic channel

Marco Weiergräber1, Marcel A Kamp, Kayalvizhi Radhakrishnan

  • 1Institute for Neurophysiology, University of Cologne, Robert-Koch-Str. 39, D 50931 Cologne, Germany. akp74@uni-koeln.de

Neuroscience and Biobehavioral Reviews
|September 12, 2006
PubMed

Insights

Calcium voltage-gated channel subtype 2.3 (Ca(v)2.3) plays a key role in triggering seizures. Targeting Ca(v)2.3 with antiepileptic drugs may offer new epilepsy treatments.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The Ca(v)2.3 calcium channel's role in neurological disorders is poorly understood.
  • Ca(v)2.3 channels are implicated in the central nervous system's (CNS) generation of epileptiform discharges.

Purpose of the Study:

  • To investigate the functional involvement of Ca(v)2.3 in the etiology and pathogenesis of seizures.
  • To explore the potential of Ca(v)2.3 as a therapeutic target for epilepsy.

Main Methods:

  • Analysis of Ca(v)2.3 channel function in triggering plateau potentials and afterdepolarizations.
  • Pharmacological profiling of antiepileptic drugs targeting Ca(v)2.3 voltage-gated calcium channels (VGCCs).
  • Seizure susceptibility assessment in Ca(v)2.3 knockout (Ca(v)2.3-/-) mice using electroencephalographic recordings.

Main Results:

  • Ca(v)2.3 channels contribute significantly to epileptiform activity in neuronal populations.
  • Specific antiepileptic drugs were found to target Ca(v)2.3 VGCCs, blocking burst activity.
  • Ca(v)2.3-/- mice exhibited significantly reduced seizure susceptibility and no ictal-like discharges.

Conclusions:

  • Ca(v)2.3 is a critical factor in triggering seizure activity.
  • Further research into Ca(v)2.3's role in human epilepsy syndromes is essential.
  • Development of novel antiepileptic drugs targeting Ca(v)2.3 presents a promising therapeutic avenue.

More Related Videos

Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes10:19

Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes

Published on: January 10, 2011

In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy (pCLE) of Hippocampal Capillaries in Awake Mice09:08

In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy (pCLE) of Hippocampal Capillaries in Awake Mice

Published on: April 21, 2023

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
The Role of Ion Channels in Neuronal Computation01:19

The Role of Ion Channels in Neuronal Computation

A postsynaptic neuron usually receives numerous impulses from several other presynaptic neurons. The axon hillock of the postsynaptic neuron integrates all these signals and determines the likelihood of firing an action potential.
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential.
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...